On October 5, 2023, Treatment.Com International Inc. closed the transaction. The company amended the terms of the transaction and issued 2,475,000 common shares in the capital of the company at a price of CAD 0.15 per common share, for aggregate gross proceeds of up to CAD 371,250. The company has received CAD 350,234 pursuant to Regulation D and included participation from 2 investors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.05 CAD | -1.87% |
|
+15.38% | +147.06% |
1st Jan change | Capi. | |
---|---|---|
+147.06% | 36.32M | |
-2.39% | 30.06B | |
+37.51% | 9.49B | |
+35.03% | 4.43B | |
-40.39% | 2.25B | |
-6.10% | 1.66B | |
-29.44% | 1.23B | |
-41.27% | 965M | |
-6.21% | 826M | |
-49.31% | 715M |
- Stock Market
- Equities
- TRUE Stock
- News Treatment.com AI Inc.
- Treatment.Com International Inc. announced that it has received CAD 0.37125 million in funding